Topical botulinum toxin type A (Eirion Therapeutics)

外用型A型肉毒毒素(Eirion Therapeutics)

Report date: 2025/05/21 14:38:27

Base Information

Drug NameTopical botulinum toxin type A (Eirion Therapeutics)
Drug Alias Name涂抹型A型肉毒毒素(Eirion Therapeutics)Botulinum toxin A topical liniment - Eirion TherapeuticsTopical ET-01ET-01
ClassificationBiologics > Protein drugs > ToxinNatural product/Extract > Microbial extract
Mechanisms of ActionSynaptosomal-associated protein 25 inhibitors
TargetsSynaptosomal-associated protein 25
Therapy Area/IndicationsNasolabial fold wrinkles
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEirion Therapeutics Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsNasolabial fold wrinkles
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A